ARIC Publications
Filters: Keyword is Glomerular Filtration Rate [Clear All Filters]
18-year change in serum intact fibroblast growth factor 23 from midlife to late life and risk of mortality: the ARIC Study." Eur J Endocrinol. 2022;187(1):39-47.
"CKD and Risk of Incident Hospitalization With Clostridioides difficile Infection: Findings From the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2022;80(2):297-299.
"Development and Validation of Prediction Models of Adverse Kidney Outcomes in the Population With and Without Diabetes." Diabetes Care. 2022;45(9):2055-2063.
"Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals." Commun Biol. 2022;5(1):580.
"Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies." Kidney Int. 2022;102(3):624-639.
"Quantifying Individual-Level Inaccuracy in Glomerular Filtration Rate Estimation : A Cross-Sectional Study." Ann Intern Med. 2022;175(8):1073-1082.
"Meta-analyses identify DNA methylation associated with kidney function and damage." Nat Commun. 2021;12(1):7174.
"Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline." Kidney Int. 2021;99(4):926-939.
" "Albuminuria, Kidney Function, and Cancer Risk in the Community." Am J Epidemiol. 2020;189(9):942-950.
"Association between kidney disease measures and intracranial atherosclerosis: The ARIC study." Neurology. 2020;94(22):e2361-e2372.
"Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium." BMJ. 2019;364:k5301.
"Association Between Hypertension and Kidney Function Decline: The Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2019;74(3):310-319.
"A catalog of genetic loci associated with kidney function from analyses of a million individuals." Nat Genet. 2019;51(6):957-972.
"Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies." Lancet Diabetes Endocrinol. 2019;7(2):115-127.
"Cost-effectiveness of Pneumococcal Vaccination Among Patients With CKD in the United States." Am J Kidney Dis. 2019;74(1):23-35.
"Hospitalization Risk among Older Adults with Chronic Kidney Disease." Am J Nephrol. 2019;50(3):212-220.
"Novel "Predictor Patch" Method for Adding Predictors Using Estimates From Outside Datasets - A Proof-of-Concept Study Adding Kidney Measures to Cardiovascular Mortality Prediction." Circ J. 2019;83(9):1876-1882.
"Plant-Based Diets and Incident CKD and Kidney Function." Clin J Am Soc Nephrol. 2019;14(5):682-691.
"Plasma total testosterone and risk of incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study." Maturitas. 2019;125:5-10.
"Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium." Am J Kidney Dis. 2019;73(2):206-217.
"Reproducibility and Variability of Protein Analytes Measured Using a Multiplexed Modified Aptamer Assay." J Appl Lab Med. 2019;4(1):30-39.
"Socioeconomic status and risk of kidney dysfunction: the Atherosclerosis Risk in Communities study." Nephrol Dial Transplant. 2019;34(8):1361-1368.
" " "Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study." JAMA Intern Med. 2018;178(7):903-910.
"Associations Between Kidney Disease Measures and Regional Pulse Wave Velocity in a Large Community-Based Cohort: The Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2018;72(5):682-690.
"Chronic kidney disease measures and the risk of abdominal aortic aneurysm." Atherosclerosis. 2018;279:107-113.
"Coffee Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2018;72(2):214-222.
"Diabetes and Trajectories of Estimated Glomerular Filtration Rate: A Prospective Cohort Analysis of the Atherosclerosis Risk in Communities Study." Diabetes Care. 2018;41(8):1646-1653.
"Hemoglobin, Albuminuria, and Kidney Function in Cardiovascular Risk: The ARIC (Atherosclerosis Risk in Communities) Study." J Am Heart Assoc. 2018;7(2).
"Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease." Kidney Int. 2018;93(1):252-259.
" and Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function." J Am Soc Nephrol. 2017;28(3):981-994.
"Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study." J Clin Endocrinol Metab. 2017;102(12):4648-4657.
"Community burden and prognostic impact of reduced kidney function among patients hospitalized with acute decompensated heart failure: The Atherosclerosis Risk in Communities (ARIC) Study Community Surveillance." PLoS One. 2017;12(8):e0181373.
"Dietary Protein Sources and Risk for Incident Chronic Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study." J Ren Nutr. 2017;27(4):233-242.
"Epigenome-wide association studies identify DNA methylation associated with kidney function." Nat Commun. 2017;8(1):1286.
"Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis." Clin J Am Soc Nephrol. 2017;12(1):69-78.
"Genome-Wide Association of Copy Number Polymorphisms and Kidney Function." PLoS One. 2017;12(1):e0170815.
"Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study." J Am Heart Assoc. 2017;6(9).
"Kidney function, bone-mineral metabolism markers, and future risk of peripheral artery disease." Atherosclerosis. 2017;267:167-174.
"Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2017;70(5):675-685.
"Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data." Lancet Diabetes Endocrinol. 2017;5(9):718-728.
"Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease." Am J Epidemiol. 2017;186(8):952-960.
"Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the Atherosclerosis Risk in Communities study." Nephrol Dial Transplant. 2017;32(11):1874-1881.
"Chronic Kidney Disease and Risk for Gastrointestinal Bleeding in the Community: The Atherosclerosis Risk in Communities (ARIC) Study." Clin J Am Soc Nephrol. 2016;11(10):1735-1743.
"Kidney Function and Fracture Risk: The Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2016;67(2):218-226.
"Kidney function and sudden cardiac death in the community: The Atherosclerosis Risk in Communities (ARIC) Study." Am Heart J. 2016;180:46-53.
"Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate." N Engl J Med. 2016;374(5):411-21.
"Past Decline Versus Current eGFR and Subsequent ESRD Risk." J Am Soc Nephrol. 2016;27(8):2447-55.
"Past Decline Versus Current eGFR and Subsequent Mortality Risk." J Am Soc Nephrol. 2016;27(8):2456-66.
"Risk prediction of major complications in individuals with diabetes: the Atherosclerosis Risk in Communities Study." Diabetes Obes Metab. 2016;18(9):899-906.
"Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study." Mayo Clin Proc. 2016;91(10):1403-1412.
"Association Between Periodontal Disease and Kidney Function Decline in African Americans: The Jackson Heart Study." J Periodontol. 2015;86(10):1126-32.
"Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study." Nephrol Dial Transplant. 2015;30(1):77-83.
"Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality." Clin J Am Soc Nephrol. 2015;10(6):941-8.
"Change in novel filtration markers and risk of ESRD." Am J Kidney Dis. 2015;66(1):47-54.
"Dietary Acid Load and Incident Chronic Kidney Disease: Results from the ARIC Study." Am J Nephrol. 2015;42(6):427-35.
"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data." Lancet Diabetes Endocrinol. 2015;3(7):514-25.
"Kidney Failure and ESRD in the Atherosclerosis Risk in Communities (ARIC) Study: Comparing Ascertainment of Treated and Untreated Kidney Failure in a Cohort Study." Am J Kidney Dis. 2015;66(2):231-9.
"Kidney measures with diabetes and hypertension on cardiovascular disease: the Atherosclerosis Risk in Communities Study." Am J Nephrol. 2015;41(4-5):409-17.
"A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury." Am J Kidney Dis. 2015;66(4):591-601.
"A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury." Am J Kidney Dis. 2015;66(4):602-12.
"Plasma Urate and Risk of a Hospital Stay with AKI: The Atherosclerosis Risk in Communities Study." Clin J Am Soc Nephrol. 2015;10(5):776-83.
"Recalibration of blood analytes over 25 years in the atherosclerosis risk in communities study: impact of recalibration on chronic kidney disease prevalence and incidence." Clin Chem. 2015;61(7):938-47.
"Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease." Kidney Int. 2015;87(4):820-7.
"Serum fibroblast growth factor-23 is associated with incident kidney disease." J Am Soc Nephrol. 2015;26(1):192-200.
"Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality." Am J Kidney Dis. 2014;63(1):16-22.
"Association of kidney disease measures with ischemic versus hemorrhagic strokes: pooled analyses of 4 prospective community-based cohorts." Stroke. 2014;45(7):1925-31.
"Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans." JAMA. 2014;312(20):2115-25.
"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality." JAMA. 2014;311(24):2518-2531.
"Identification of incident CKD stage 3 in research studies." Am J Kidney Dis. 2014;64(2):214-21.
"Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar." Kidney Int. 2014;86(4):819-27.
"CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: interactions with age, sex, and race." Am J Kidney Dis. 2013;62(4):691-702.
"Cohort profile: the chronic kidney disease prognosis consortium." Int J Epidemiol. 2013;42(6):1660-8.
"Cystatin C versus creatinine in determining risk based on kidney function." N Engl J Med. 2013;369(10):932-43.
"Genome-wide association study identified the human leukocyte antigen region as a novel locus for plasma beta-2 microglobulin." Hum Genet. 2013;132(6):619-27.
"Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: the CKDGen consortium." Am J Kidney Dis. 2013;61(6):889-98.
"Using multiple measures for quantitative trait association analyses: application to estimated glomerular filtration rate." J Hum Genet. 2013;58(7):461-6.
"Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samples." Nephrol Dial Transplant. 2012;27(7):2839-47.
"